Evotec Stock (NASDAQ: EVO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 109.744K |
Day Range | - - - |
52 Wk Range | 4.870 - 13.492 |
Market Cap | $1.821B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 0.02% |
Days to Cover | 1.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evotec (NASDAQ: EVO) through any online brokerage.
Other companies in Evotec’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Evotec (NASDAQ: EVO) was reported by HC Wainwright & Co. on Thursday, April 25, 2024. The analyst firm set a price target for 11.00 expecting EVO to rise to within 12 months (a possible 114.01% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Evotec (NASDAQ: EVO) is $5.14 last updated May 8, 2024 at 8:38 AM EDT.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on January 22, 2019 to stockholders of record on January 11, 2019.
Evotec’s Q1 earnings are confirmed for Friday, May 24, 2024.
There is no upcoming split for Evotec.
Evotec is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.